Herceptin (trastuzumab) 440 mg powder for concentrate for solution for infusion — original (Roche) Indications 1. Breast cancer 2. Metastatic breast cancer with HER2 overexpression: Delivery to Ukraine in 5-6 days, +380996042415
600 mg for subcutaneous administration - $750
Indications
1. Breast cancer
2. Metastatic breast cancer with tumor overexpression of HER2:
3. Breast cancer with tumor overexpression of HER2 (early stages)
4. Metastatic gastric cancer or gastroesophageal junction cancer
- Trade Name:Herceptin
- Chemical Name:Trastuzumab
- Dosage:440 mg
- Quantity:1
- Form of Issue:Flacon
- Manufacturer:Roche. Switzerland
No reviews yet